Equities

Sawai Group Holdings Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Sawai Group Holdings Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)1,834.00
  • Today's Change-13.00 / -0.70%
  • Shares traded50.10k
  • 1 Year change-17.99%
  • Beta0.4337
Data delayed at least 15 minutes, as of Jul 10 2025 02:33 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sawai Group Holdings Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of medical and over-the-counter drugs. The Company operates in two segments. The Japan segment is engaged in medical and healthcare-related businesses such as manufacture and sale of pharmaceuticals and medical devices, as well as various related businesses. The America segment is engaged in the sale of manufactured pharmaceutical products to wholesale stores in America. The company is also engaged in the research and development of pharmaceutical products.

  • Revenue in JPY (TTM)189.02bn
  • Net income in JPY2.17bn
  • Incorporated2021
  • Employees3.31k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
4887:TYO since
announced
Transaction
value
FrontactDeal completed28 Mar 202528 Mar 2025Deal completed-12.67%--
Data delayed at least 15 minutes, as of Jul 10 2025 02:33 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Zeria Pharmaceutical Co Ltd87.31bn9.94bn107.62bn1.75k8.990.99746.141.23225.42225.421,980.762,031.330.56381.513.7050,006,380.006.444.679.957.4773.2572.1711.429.020.9752--0.320928.7515.307.6428.5227.7116.516.69
Towa Pharmaceutical Co Ltd259.59bn18.99bn152.33bn4.79k7.670.84823.900.5868385.70385.705,273.633,486.390.57591.573.6954,217,630.004.213.895.185.0736.4937.817.316.611.58--0.573721.5213.8918.6517.395.5346.239.73
Kaken Pharmaceutical Co Ltd94.04bn13.95bn165.08bn1.13k10.050.94110.011.76372.31372.312,464.103,974.440.51951.964.2383,512,430.007.705.998.926.8762.2556.1714.8312.913.04--0.024659.5830.521.0573.77-6.3614.810.00
Torii Pharmaceutical Co Ltd61.66bn5.56bn182.02bn592.0031.981.4730.562.95197.61197.612,193.404,311.560.45732.462.25104,152,000.004.123.014.593.3644.3947.879.017.915.15--0.0061.3210.597.0422.41-28.70-19.9020.11
Kissei Pharmaceutical Co Ltd88.33bn11.96bn184.54bn1.78k14.440.812111.122.09274.64274.642,024.904,882.690.34981.733.0449,679,420.004.744.265.114.6049.8948.5913.5614.304.95--0.007532.4116.876.917.1833.5431.0413.97
Sawai Group Holdings Co Ltd189.02bn2.17bn209.03bn3.31k194.351.2012.001.119.3282.531,518.811,505.860.51321.263.5657,106,950.000.590-0.23270.8126-0.318729.8132.951.15-0.4750.88474.560.3536191.656.880.7009-87.38-35.388.654.11
Nippon Shinyaku Co Ltd160.23bn32.56bn219.04bn2.24k6.450.85055.681.37483.40483.402,379.023,666.270.58581.253.6371,436,470.0011.9010.8913.6012.7468.1063.9320.3217.673.54--0.010930.588.086.5625.9414.0680.487.59
Tsumura & Co181.09bn32.43bn269.96bn4.27k8.230.88635.911.49427.12427.122,385.353,968.060.40580.722.7342,390,680.007.745.539.756.8550.0249.3919.0614.502.62--0.176631.6520.058.0094.1018.6923.0716.27
Hisamitsu Pharmaceutical Co Inc156.01bn21.76bn301.04bn2.80k13.551.0610.511.93295.53295.532,116.233,794.070.46442.983.4755,736,340.006.644.347.774.9958.4657.8314.3010.323.84--0.013650.2910.092.0455.763.0829.890.7127
Data as of Jul 10 2025. Currency figures normalised to Sawai Group Holdings Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

34.57%Per cent of shares held by top holders
HolderShares% Held
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 30 Apr 20258.81m6.71%
Nomura Asset Management Co., Ltd.as of 14 Mar 20258.65m6.58%
Silchester International Investors LLPas of 17 Mar 20257.52m5.72%
FIL Investments (Japan) Ltd.as of 31 May 20254.44m3.37%
The Vanguard Group, Inc.as of 02 Jul 20253.99m3.03%
JPMorgan Asset Management (Japan) Ltd.as of 31 Dec 20243.36m2.55%
Goldman Sachs Asset Management LPas of 06 Jul 20252.54m1.93%
Nikko Asset Management Co., Ltd.as of 15 Oct 20242.20m1.67%
Daiwa Asset Management Co. Ltd.as of 30 May 20251.99m1.52%
Dimensional Fund Advisors LPas of 04 Jul 20251.96m1.49%
More ▼
Data from 31 Mar 2025 - 04 Jul 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.